Mizuho Maintains Buy on Encompass Health, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes maintains a Buy rating on Encompass Health (NYSE:EHC) and raises the price target from $93 to $95.
April 25, 2024 | 11:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst Ann Hynes reaffirms a Buy rating on Encompass Health and increases the price target to $95.
The upgrade in price target by a reputable analyst like Ann Hynes suggests a positive outlook on Encompass Health's stock, potentially leading to increased investor confidence and a short-term price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100